Rocket Pharmaceuticals In...
(RCKT)
undefined
undefined%
At close: undefined
12.02
0.04%
After-hours Dec 13, 2024, 05:19 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts,
total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Cash & Equivalents | 55.90M | 140.52M | 232.69M | 297.10M | 185.38M | 111.36M | 78.72M | 29.80M | 80.04M | 3.62M | 12.79M | 1.37M |
| Short-Term Investments | 317.27M | 215.88M | 156.05M | 185.62M | 118.73M | 94.38M | 21.29M | 96.67M | 31.24M | - | - | - |
| Long-Term Investments | 34.32M | 43.28M | 1.34M | 1.57M | 1.52M | 7.40M | 207.00K | - | - | - | - | - |
| Other Long-Term Assets | 1.91M | 1.95M | 1.80M | 2.02M | 1.98M | 1.44M | -39.00K | 168.00K | 143.00K | 1.90M | 4.00K | 4.00K |
| Receivables | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 5.05M | 7.67M | 6.64M | 9.25M | 7.28M | 6.72M | 1.03M | 1.88M | 2.17M | 104.00K | 66.00K | 45.00K |
| Total Current Assets | 378.22M | 364.06M | 392.06M | 487.35M | 307.75M | 209.09M | 101.05M | 128.35M | 112.37M | 3.62M | 12.86M | 1.42M |
| Property-Plant & Equipment | 87.59M | 77.64M | 72.35M | 70.64M | 31.35M | 2.03M | 563.00K | 1.13M | 812.00K | - | - | - |
| Goodwill & Intangibles | 64.30M | 64.88M | 30.82M | 30.82M | 31.04M | 30.82M | - | - | - | - | - | - |
| Total Long-Term Assets | 188.12M | 187.75M | 104.96M | 103.48M | 64.37M | 42.23M | 731.00K | 1.30M | 955.00K | 1.90M | 4.00K | 4.00K |
| Total Assets | 566.34M | 551.81M | 497.02M | 590.82M | 372.12M | 251.31M | 101.78M | 129.65M | 113.32M | 5.52M | 12.86M | 1.42M |
| Account Payables | - | - | - | - | - | - | 451.00K | 1.59M | 1.63M | 1.15M | 229.00K | 387.00K |
| Deferred Revenue | - | -36.66M | -482 | 590.00K | 562.00K | 534.00K | 506.00K | 478.00K | 450.00K | 421.00K | 394.00K | 367.00K |
| Short-Term Debt | 5.43M | 5.02M | 5.10M | 9.41M | 1.91M | - | - | - | - | 5.08M | 693.00K | 2.21M |
| Other Current Liabilities | 43.07M | 34.15M | 17.06M | 23.20M | 16.39M | 15.37M | 3.11M | 5.62M | 2.51M | -2.53M | 1.19M | 298.00K |
| Total Current Liabilities | 48.51M | 39.17M | 22.17M | 32.62M | 18.31M | 15.37M | 4.07M | 7.21M | 4.14M | 3.70M | 3.22M | 3.77M |
| Long-Term Debt | 44.65M | 40.71M | 40.10M | 74.04M | 47.94M | 41.45M | 49.54M | 48.96M | - | 2.55M | 5.39M | - |
| Other Long-Term Liabilities | -19.39M | -17.76M | -19.97M | -19.35M | -1.42M | 457.00K | 403.00K | 307.00K | 367.00K | 50.83M | 43.15M | 28.59M |
| Total Long-Term Liabilities | 25.26M | 22.95M | 20.13M | 54.69M | 46.52M | 41.90M | 49.94M | 49.27M | 367.00K | 53.38M | 48.54M | 28.59M |
| Total Liabilities | 73.77M | 62.12M | 42.30M | 87.31M | 64.82M | 57.28M | 54.01M | 56.48M | 4.51M | 57.08M | 51.76M | 32.35M |
| Total Debt | 25.04M | 22.87M | 22.60M | 61.70M | 47.45M | 41.45M | 49.54M | 48.96M | 14.00 | 7.15M | 6.80M | 2.71M |
| Common Stock | 903.00K | 791.00K | 645.00K | 610.00K | 548.00K | 452.00K | 68.00K | 270.00K | 264.00K | 10.00K | 10.00K | 10.00K |
| Retained Earnings | -959.37M | -713.77M | -491.91M | -322.84M | -183.14M | -105.87M | -268.37M | -238.88M | -196.02M | -128.04M | -118.51M | -110.89M |
| Comprehensive Income | 319.00K | -357.00K | -161.00K | -42.00K | 20.00K | -127.00K | -16.00K | -54.00K | -11.00K | -217.00K | -217.00K | -217.00K |
| Shareholders Equity | 492.57M | 489.69M | 454.72M | 503.52M | 307.30M | 194.04M | 47.76M | 73.17M | 108.81M | -51.56M | -38.90M | -30.93M |
| Total Investments | 351.59M | 259.15M | 156.05M | 185.62M | 118.73M | 101.78M | 21.29M | 96.67M | 31.24M | - | - | - |